|
Volumn 18, Issue 6, 2010, Pages 419-422
|
[A pilot study of peginterferon alfa-2a combined with short-term lamivudine therapy in HBeAg-positive chronic hepatitis B patients].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ALPHA2A INTERFERON;
ANTIVIRUS AGENT;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
MACROGOL DERIVATIVE;
PEGINTERFERON ALPHA2A;
RECOMBINANT PROTEIN;
VIRUS DNA;
ADULT;
ARTICLE;
BLOOD;
CLINICAL TRIAL;
DRUG COMBINATION;
FEMALE;
HEPATITIS B;
HUMAN;
MALE;
PILOT STUDY;
TREATMENT OUTCOME;
ADULT;
ANTIVIRAL AGENTS;
DNA, VIRAL;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPATITIS B E ANTIGENS;
HEPATITIS B, CHRONIC;
HUMANS;
INTERFERON-ALPHA;
LAMIVUDINE;
MALE;
PILOT PROJECTS;
POLYETHYLENE GLYCOLS;
RECOMBINANT PROTEINS;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 79959742834
PISSN: 10073418
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|